Literature DB >> 23376227

Drug carriers in osteoporosis: preparation, drug encapsulation and applications.

K Miladi1, S Sfar, H Fessi, A Elaissari.   

Abstract

Carriers are largely used to enhance therapy efficiency via the encapsulation of active molecules. The encapsulation enhances the stability of drug molecules, improves the targeting properties and prolongs pharmacological activity via continuous local release of active molecules. The aim of this review is to report the carrier systems used in osteoporosis therapy. This state of the art research has mainly focused on describing all types of carriers used in this area, their elaboration and properties, the drug characteristics used in such specific application, and drug release and efficiency. In this field, various processes have been used in order to obtain well-defined capsules, spheres and more complex carriers. In this exhaustive review, each process is described, illustrated and discussed.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376227     DOI: 10.1016/j.ijpharm.2013.01.031

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

Review 1.  Advances in Controlled Drug Delivery for Treatment of Osteoporosis.

Authors:  T A Asafo-Adjei; A J Chen; A Najarzadeh; D A Puleo
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

2.  Development of local strontium ranelate delivery systems and long term in vitro drug release studies in osteogenic medium.

Authors:  Dagnija Loca; Anastasija Smirnova; Janis Locs; Arita Dubnika; Jana Vecstaudza; Liga Stipniece; Elina Makarova; Maija Dambrova
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

3.  Oral Delivery of Teriparatide Using a Nanoemulsion System: Design, in Vitro and in Vivo Evaluation.

Authors:  Bashar M Altaani; Ammar M Almaaytah; Suha Dadou; Khouloud Alkhamis; Mousa H Daradka; Wael Hananeh
Journal:  Pharm Res       Date:  2020-04-06       Impact factor: 4.200

4.  Formulation and In Vitro Evaluation of Alendronate Sodium/PLGA Microspheres for Applications in Bone Related Disorders.

Authors:  A G Deca; I Belu; O Croitoru; M V Bubulică; C V Manda; J Neamtu
Journal:  Curr Health Sci J       Date:  2015-03-15

Review 5.  Fab on a Package: LTCC Microfluidic Devices Applied to Chemical Process Miniaturization.

Authors:  Houari Cobas Gomez; Roberta Mansini Cardoso; Juliana de Novais Schianti; Adriano Marim de Oliveira; Mario Ricardo Gongora-Rubio
Journal:  Micromachines (Basel)       Date:  2018-06-05       Impact factor: 2.891

Review 6.  Particles from preformed polymers as carriers for drug delivery.

Authors:  K Miladi; D Ibraheem; M Iqbal; S Sfar; H Fessi; A Elaissari
Journal:  EXCLI J       Date:  2014-02-03       Impact factor: 4.068

7.  Alendronate Sodium Intercalation in Layered Double Hydroxide/Poly (ε-caprolactone): Application in Osteoporosis Treatment.

Authors:  Faranak Baniahmad; Soroor Yousefi; Mohammad Rabiee; Seyedeh Sara Shafiei; Shahab Faghihi
Journal:  Iran J Biotechnol       Date:  2021-01-01       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.